MX2017007295A - Modelo animal de ojo seco y metodos de uso de dichos animales. - Google Patents

Modelo animal de ojo seco y metodos de uso de dichos animales.

Info

Publication number
MX2017007295A
MX2017007295A MX2017007295A MX2017007295A MX2017007295A MX 2017007295 A MX2017007295 A MX 2017007295A MX 2017007295 A MX2017007295 A MX 2017007295A MX 2017007295 A MX2017007295 A MX 2017007295A MX 2017007295 A MX2017007295 A MX 2017007295A
Authority
MX
Mexico
Prior art keywords
methods
dry eye
animal model
animals
treatments
Prior art date
Application number
MX2017007295A
Other languages
English (en)
Spanish (es)
Inventor
Cao Jingtai
Hu Ying
Yuan Ming
Romano Carmelo
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2017007295A publication Critical patent/MX2017007295A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/20—Animals treated with compounds which are neither proteins nor nucleic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Animal Husbandry (AREA)
  • Educational Technology (AREA)
  • Pure & Applied Mathematics (AREA)
  • Medical Informatics (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)
  • Theoretical Computer Science (AREA)
  • Algebra (AREA)
  • Business, Economics & Management (AREA)
MX2017007295A 2014-12-02 2015-12-01 Modelo animal de ojo seco y metodos de uso de dichos animales. MX2017007295A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462086263P 2014-12-02 2014-12-02
PCT/US2015/063084 WO2016089807A1 (en) 2014-12-02 2015-12-01 Animal model for dry eye and methods of use of such animals

Publications (1)

Publication Number Publication Date
MX2017007295A true MX2017007295A (es) 2018-03-12

Family

ID=55024246

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007295A MX2017007295A (es) 2014-12-02 2015-12-01 Modelo animal de ojo seco y metodos de uso de dichos animales.

Country Status (14)

Country Link
US (1) US20170360013A1 (enExample)
EP (1) EP3226853B1 (enExample)
JP (1) JP6692808B2 (enExample)
KR (1) KR20170100483A (enExample)
CN (1) CN107106553A (enExample)
AU (1) AU2015355169A1 (enExample)
CA (1) CA2967432A1 (enExample)
ES (1) ES2759729T3 (enExample)
IL (1) IL252077A0 (enExample)
MX (1) MX2017007295A (enExample)
RU (1) RU2706787C2 (enExample)
SG (1) SG11201703572SA (enExample)
WO (1) WO2016089807A1 (enExample)
ZA (1) ZA201703052B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2909998T3 (es) * 2016-10-14 2022-05-11 I Com Medical Gmbh Método para establecer, restablecer y preservar la homeostasis de la superficie ocular
US12303527B2 (en) 2018-04-18 2025-05-20 i.com medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
US12268706B2 (en) 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
KR102429281B1 (ko) * 2020-05-25 2022-08-05 (주)노바셀테크놀로지 신규 안구건조증 치료용 약학적 조성물
CN113519461A (zh) * 2021-07-06 2021-10-22 江西中洪博元生物技术有限公司 伴刀豆球蛋白a诱导的小鼠干眼症模型的构建方法及应用
WO2023215261A1 (en) * 2022-05-02 2023-11-09 Ocular Services On Demand, Llc Mammalian eye models

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2384679A1 (en) * 1999-09-08 2001-03-15 Srinivasan Venkateshwaran Using quaternary ammonium salts for transdermal drug delivery
EP2598131A1 (fr) * 2010-07-29 2013-06-05 Laboratoires Fournier S.A. Composes pour le traitement/la prevention des maladies inflammatoires oculaires

Also Published As

Publication number Publication date
RU2017118978A (ru) 2019-01-09
ES2759729T3 (es) 2020-05-12
RU2706787C2 (ru) 2019-11-21
EP3226853A1 (en) 2017-10-11
CN107106553A (zh) 2017-08-29
KR20170100483A (ko) 2017-09-04
SG11201703572SA (en) 2017-05-30
CA2967432A1 (en) 2016-06-09
US20170360013A1 (en) 2017-12-21
IL252077A0 (en) 2017-07-31
RU2017118978A3 (enExample) 2019-06-04
JP6692808B2 (ja) 2020-05-13
EP3226853B1 (en) 2019-09-04
AU2015355169A1 (en) 2017-05-25
WO2016089807A1 (en) 2016-06-09
ZA201703052B (en) 2019-03-27
JP2018500546A (ja) 2018-01-11

Similar Documents

Publication Publication Date Title
IL272339A (en) Cellular models of and therapies for ocular diseases
IL283561B (en) Methods for treating ocular diseases
EP3534772A4 (en) ORBITAL FABRIC SPREADER
IL255533A0 (en) Real time electroanatomical coloring of the heart
IL251972B (en) Analyzing and utilizing landscapes
IL288409A (en) Methods for gender determination of avian embryos in unhatched eggs and means thereof
DK3142637T3 (da) Keratin treatment formulations and methods
EP3518783A4 (en) DEVICE AND METHOD FOR TISSUE REDUCTION
DK3151875T3 (da) Humane lever-scaffolds
EP3585393A4 (en) FORMULAS FOR EYE TREATMENTS
MX2017005975A (es) Anticuerpos anti factor de crecimiento derivado de plaquetas b (pdgf-b) y metodos de uso.
ZA201703052B (en) Animal model for dry eye and methods of use of such animals
MX392383B (es) Metodos para tratar afecciones oculares.
TWD169884S (zh) 動物互動裝置
HUE063641T2 (hu) Készítmények és eljárások immunválaszok modulálására és/vagy stimulálására emberben és/vagy állatban
PL3151666T3 (pl) Modele zwierzęce angiogenezy rogówki oraz chorób rozstrzeniowych rogówki, sposoby wytwarzania i sposoby ich zastosowania
DK3384778T3 (da) Indretning til anvendelse i den humane slagtning af dyr
GB201705390D0 (en) Device for use in the humane slaughter of animals
HUE048864T2 (hu) Lizobaktin szarvasmarhafélék tõgygyulladásának kezelésében történõ alkalmazásra
HK1239525A1 (en) Animal model for dry eye and methods of use of such animals
DK3177229T3 (da) Kunstig insemineringssonde til kvæg såsom svin
IL265209A (en) In vitro neonatal biomimetic (nmimic) model and methods of using same
GB201506044D0 (en) Methods for determining the effect of an agent on tissue stem cells
TH1601002237A (th) องค์ประกอบเสริมฤทธิ์ฆ่าศัตรูพืชเเละสัตว์เเละวิธีที่เกี่ยวข้อง
TH1601000957A (th) วิธีสำหรับการสร้างเนื้อเยื่อเรตินาและเซลล์ที่เกี่ยวข้องกับเรตินา